International Journal of Pharmaceutical Investigation – a peer-reviewed scholarly journal that is dedicated to disseminating research and knowledge within the realm of pharmaceutical sciences. Its primary aim is to facilitate the distribution of scientific information by publishing a variety of works, including research papers, reviews, and commentaries related to pharmaceutical drug delivery and related disciplines. The journal encourages the submission of unsolicited expert reviews and research articles in all aspects of this field. The types of manuscripts accepted include original research papers, in-depth review articles, short communications, letters to the editor, and critical commentaries. All of these work to provide a well-rounded understanding of key issues in pharmaceutical drug delivery.
ISSN : [Print -2230-973X, Online – 2230-9713] ; Frequency : Rapid at a time publication – Quarterly (4 issues/year). Special issues are also published on contemporary areas from time-to-time.
Editor-in-Chief: Dr. Vanaja K, Ph.D | View Editorial Board
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing’s Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data
The journal is indexed with, or included in, the following:
Emerging Sources Citation Index, Index Copernicus, Web of Science
The submission of all manuscripts is compulsory via the designated online platform. First-time users are required to register on the platform, which entails a mandatory and cost-free registration process. Once registered, authors can conveniently monitor the progress of their articles by logging in with their unique username and password. To facilitate the publication of articles, authors are expected to fulfill the necessary Article Processing Charges. Should any difficulties arise during the submission or payment process, please do not hesitate to reach out to the editorial office at email@example.com.
Aim and Scope
Research studies, original articles and reviews relating to Pharmacy subjects as well as allied subjects will be published in the journal. Articles with current interest and newer concepts will be given a priority.
The journal aims to cater for the latest outstanding developments in the field of Pharmaceutical Sciences and Technology covering the following topics (non-limiting):
- Current Novel Drug Delivery Systems
- Quality control of Pharmaceuticals
- Quality Assurance
- National and International Regulatory Affairs
- Validation Techniques
- Industrial Pharmacy
- Biopharmaceutics and Drug Disposition
- Drug Development
- Pharmaceutical Intellectual Property Rights.
Other Allied Pharmacy Subjects
- Pharmacognosy & Ethnopharmacology
- Pharm Chemistry & Medicinal Chemistry
- Pharmacy Practice
The International Journal of Pharmaceutical Investigation (Int J. Pharm. Investigation) publishes original research results, reviews, and opinions to improve our understanding of pharmacy and pharmaceutical sciences. Research articles, reviews, commentaries, letters to editors, book reviews, and other papers can be submitted to the Journal.
The acceptable word limit for an original article is 3500-4000, review articles should be up to 3500 words, and commentaries should not be more than 700 words. Original articles, review articles, reprint articles and case reports need to be peer-reviewed.
Abstracts should be structured with not more than 250 to 300 words. Structured abstract must include background, purpose, methods, results and conclusion (in this order only).
Article Processing Charges
The article processing charges for the International Journal of Pharmaceutical Investigation (Int J. Pharm. Investigation) are collected by EManuscript Technologies.
If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license.
The article processing charge (APC) for this journal is INR 11800 Incl. taxes for India and US$500 plus taxes for the rest of the world.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. The journal offers waivers to authors from Lower middle-Income Countries (10% waiver on the actual APC) and authors from Lower-Income Countries (25% waiver on the actual APC) depending on the quality of work and other special considerations. The Journal reserves the right to approve or reject any waiver application. The waiver decision will be communicated to the corresponding author within one week after the request is received.
If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement. Once your manuscript files have been checked for EManuscript Production, the corresponding author will be asked to pay the article processing charge (APC) via a payment link. Once the APC has been processed, your article will be prepared for publication and can appear online within an average of 30 days. Please note that no production work will occur on your paper until the APC has been received.
We at the Journal of International Journal of Pharmaceutical Investigation (Int J. Pharm. Investigation) are committed to meeting and maintaining ethical standards throughout the publication. For these reasons, the journal closely follows industry associations like the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the World Association of Medical Editors (WAME), which define standards and provide guidance.
Authors reporting in vivo animal experiments and clinical trials are encouraged to refer to one of our associated journals about the ARRIVE guidelines (http://www.jpharmacol.com/text.asp?2010/1/2/94/72351) and the CONSORT statement (http://www.jpharmacol.com/text.asp?2010/1/2/100/72352) respectively and use the checklists given within them to improve the quality of the manuscripts. The checklists (Animal Experiments, Clinical Trial) must be downloaded, filled in and submitted along with the manuscripts. This would not only help the authors to include all the important information while preparing the manuscript but also speed up the peer review process
Peer Review Policy
A peer review process is applied to articles or information submitted exclusively to International Journal of Pharmaceutical Investigation. Manuscripts that do not meet scientific standards will not be reviewed. Referees are asked for advice on the paper’s scientific merit as well as its appeal to a broad pharmaceutical research audience. Editors usually give reviewers 21 days to complete the review process. While editors always strive for a quick turnaround, this is not always possible. After the paper has been sent to the referees, editors will contact them with weekly reminders about their due dates. Once all the reviews have been completed in-house, the Editor handling the manuscript will most likely make a decision within a day or two. The Editor will then inform the corresponding author of his or her decision. Reviewers invest valuable time in the belief that they are making a valuable contribution to the scientific process by reviewing articles submitted to International Journal of Pharmaceutical Investigation online and digitally. Communication at Int J. Pharm. Investigation occurs only via email.
A manuscript will be reviewed for possible publication with the understanding that it is being submitted to the International Journal of Pharmaceutical Investigation alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the International Journal of Pharmaceutical Investigation readers are also liable to be rejected at this stage itself.
Manuscripts found suitable for publication in the International Journal of Pharmaceutical Investigation are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identities. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in the manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point-by-point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to the final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as ‘Ahead of Print’ immediately upon acceptance.
Authorship credit should be based only on substantial contributions to each of the three components mentioned below:
- Concept and design of study or acquisition of data or analysis and interpretation of data;
- Drafting the article or revising it critically for important intellectual content; and
- Final approval of the version to be published.
Participation solely in the acquisition of funding or data collection does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing of the manuscript. Once submitted the order cannot be changed without the written consent of all the contributors. The journal prescribes a maximum number of authors for manuscripts depending upon the type of manuscript, its scope and the number of institutions involved (vide infra). The authors should provide a justification if the number of authors exceeds these limits.
Conflicts of Interest/ Competing Interests
All authors must disclose any and all conflicts of interest they may have with the publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflicts of interest with products that compete with those mentioned in their manuscript.
It is required that manuscripts conform to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” http://www.icmje.org/. Contributions and manuscripts must only be submitted to Int J. Pharm. Investigation in English. Typewritten manuscripts (double-spaced) must have liberal margins and space at the top and bottom.
It is mandatory to submit all manuscripts online through the submission website, which requires first-time users to register. Registration is free but mandatory. After logging into the site with their username and password, registered authors can keep track of their articles. In order to submit, process, or publish articles, authors must pay. If you encounter any problems, please contact the editorial office at firstname.lastname@example.org.
Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the International Journal of Pharmaceutical Investigation editorial office as follows: